Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia)
Clinical trial NCT04826172 · COMPLETED
Trial details
- NCT number
- NCT04826172
- Sponsor
- Imbria Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-23
- Primary completion
- 2023-09-21
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.